Global Treatment for Communicable Diseases Market Size, Status and Forecast 2020-2026

May 2020 | 95 pages | ID: GE989D142E99EN
QYResearch

Abstracts

This report focuses on the global Treatment for Communicable Diseases status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Treatment for Communicable Diseases development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Novartis
• Gilead
• GSK
• Janssen Pharmaceutical
• Roche
• BioCryst Pharmaceuticals
• Merck
• Boehringer Ingelheim

Market segment by Type, the product can be split into

• HIV
• Influenza
• TB
• Malaria
• Hepatitis
• HPV

Market segment by Application, split into

• Hospital
• Clinic
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Treatment for Communicable Diseases status, future forecast, growth opportunity, key market and key players.
• To present the Treatment for Communicable Diseases development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Treatment for Communicable Diseases are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Treatment for Communicable Diseases Revenue
1.4 Market Analysis by Type
  1.4.1 Global Treatment for Communicable Diseases Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 HIV
  1.4.3 Influenza
  1.4.4 TB
  1.4.5 Malaria
  1.4.6 Hepatitis
  1.4.7 HPV
1.5 Market by Application
  1.5.1 Global Treatment for Communicable Diseases Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Treatment for Communicable Diseases Market Perspective (2015-2026)
2.2 Treatment for Communicable Diseases Growth Trends by Regions
  2.2.1 Treatment for Communicable Diseases Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Treatment for Communicable Diseases Historic Market Share by Regions (2015-2020)
  2.2.3 Treatment for Communicable Diseases Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Treatment for Communicable Diseases Market Growth Strategy
  2.3.6 Primary Interviews with Key Treatment for Communicable Diseases Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Treatment for Communicable Diseases Players by Market Size
  3.1.1 Global Top Treatment for Communicable Diseases Players by Revenue (2015-2020)
  3.1.2 Global Treatment for Communicable Diseases Revenue Market Share by Players (2015-2020)
  3.1.3 Global Treatment for Communicable Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Treatment for Communicable Diseases Market Concentration Ratio
  3.2.1 Global Treatment for Communicable Diseases Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Treatment for Communicable Diseases Revenue in 2019
3.3 Treatment for Communicable Diseases Key Players Head office and Area Served
3.4 Key Players Treatment for Communicable Diseases Product Solution and Service
3.5 Date of Enter into Treatment for Communicable Diseases Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Treatment for Communicable Diseases Historic Market Size by Type (2015-2020)
4.2 Global Treatment for Communicable Diseases Forecasted Market Size by Type (2021-2026)

5 TREATMENT FOR COMMUNICABLE DISEASES BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Treatment for Communicable Diseases Market Size by Application (2015-2020)
5.2 Global Treatment for Communicable Diseases Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Treatment for Communicable Diseases Market Size (2015-2020)
6.2 Treatment for Communicable Diseases Key Players in North America (2019-2020)
6.3 North America Treatment for Communicable Diseases Market Size by Type (2015-2020)
6.4 North America Treatment for Communicable Diseases Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Treatment for Communicable Diseases Market Size (2015-2020)
7.2 Treatment for Communicable Diseases Key Players in Europe (2019-2020)
7.3 Europe Treatment for Communicable Diseases Market Size by Type (2015-2020)
7.4 Europe Treatment for Communicable Diseases Market Size by Application (2015-2020)

8 CHINA

8.1 China Treatment for Communicable Diseases Market Size (2015-2020)
8.2 Treatment for Communicable Diseases Key Players in China (2019-2020)
8.3 China Treatment for Communicable Diseases Market Size by Type (2015-2020)
8.4 China Treatment for Communicable Diseases Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Treatment for Communicable Diseases Market Size (2015-2020)
9.2 Treatment for Communicable Diseases Key Players in Japan (2019-2020)
9.3 Japan Treatment for Communicable Diseases Market Size by Type (2015-2020)
9.4 Japan Treatment for Communicable Diseases Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Treatment for Communicable Diseases Market Size (2015-2020)
10.2 Treatment for Communicable Diseases Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Treatment for Communicable Diseases Market Size by Type (2015-2020)
10.4 Southeast Asia Treatment for Communicable Diseases Market Size by Application (2015-2020)

11 INDIA

11.1 India Treatment for Communicable Diseases Market Size (2015-2020)
11.2 Treatment for Communicable Diseases Key Players in India (2019-2020)
11.3 India Treatment for Communicable Diseases Market Size by Type (2015-2020)
11.4 India Treatment for Communicable Diseases Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Treatment for Communicable Diseases Market Size (2015-2020)
12.2 Treatment for Communicable Diseases Key Players in Central & South America (2019-2020)
12.3 Central & South America Treatment for Communicable Diseases Market Size by Type (2015-2020)
12.4 Central & South America Treatment for Communicable Diseases Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Novartis
  13.1.1 Novartis Company Details
  13.1.2 Novartis Business Overview and Its Total Revenue
  13.1.3 Novartis Treatment for Communicable Diseases Introduction
  13.1.4 Novartis Revenue in Treatment for Communicable Diseases Business (2015-2020))
  13.1.5 Novartis Recent Development
13.2 Gilead
  13.2.1 Gilead Company Details
  13.2.2 Gilead Business Overview and Its Total Revenue
  13.2.3 Gilead Treatment for Communicable Diseases Introduction
  13.2.4 Gilead Revenue in Treatment for Communicable Diseases Business (2015-2020)
  13.2.5 Gilead Recent Development
13.3 GSK
  13.3.1 GSK Company Details
  13.3.2 GSK Business Overview and Its Total Revenue
  13.3.3 GSK Treatment for Communicable Diseases Introduction
  13.3.4 GSK Revenue in Treatment for Communicable Diseases Business (2015-2020)
  13.3.5 GSK Recent Development
13.4 Janssen Pharmaceutical
  13.4.1 Janssen Pharmaceutical Company Details
  13.4.2 Janssen Pharmaceutical Business Overview and Its Total Revenue
  13.4.3 Janssen Pharmaceutical Treatment for Communicable Diseases Introduction
  13.4.4 Janssen Pharmaceutical Revenue in Treatment for Communicable Diseases Business (2015-2020)
  13.4.5 Janssen Pharmaceutical Recent Development
13.5 Roche
  13.5.1 Roche Company Details
  13.5.2 Roche Business Overview and Its Total Revenue
  13.5.3 Roche Treatment for Communicable Diseases Introduction
  13.5.4 Roche Revenue in Treatment for Communicable Diseases Business (2015-2020)
  13.5.5 Roche Recent Development
13.6 BioCryst Pharmaceuticals
  13.6.1 BioCryst Pharmaceuticals Company Details
  13.6.2 BioCryst Pharmaceuticals Business Overview and Its Total Revenue
  13.6.3 BioCryst Pharmaceuticals Treatment for Communicable Diseases Introduction
  13.6.4 BioCryst Pharmaceuticals Revenue in Treatment for Communicable Diseases Business (2015-2020)
  13.6.5 BioCryst Pharmaceuticals Recent Development
13.7 Merck
  13.7.1 Merck Company Details
  13.7.2 Merck Business Overview and Its Total Revenue
  13.7.3 Merck Treatment for Communicable Diseases Introduction
  13.7.4 Merck Revenue in Treatment for Communicable Diseases Business (2015-2020)
  13.7.5 Merck Recent Development
13.8 Boehringer Ingelheim
  13.8.1 Boehringer Ingelheim Company Details
  13.8.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  13.8.3 Boehringer Ingelheim Treatment for Communicable Diseases Introduction
  13.8.4 Boehringer Ingelheim Revenue in Treatment for Communicable Diseases Business (2015-2020)
  13.8.5 Boehringer Ingelheim Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Treatment for Communicable Diseases Key Market Segments
Table 2. Key Players Covered: Ranking by Treatment for Communicable Diseases Revenue
Table 3. Ranking of Global Top Treatment for Communicable Diseases Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Treatment for Communicable Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of HIV
Table 6. Key Players of Influenza
Table 7. Key Players of TB
Table 8. Key Players of Malaria
Table 9. Key Players of Hepatitis
Table 10. Key Players of HPV
Table 11. Global Treatment for Communicable Diseases Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Treatment for Communicable Diseases Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Treatment for Communicable Diseases Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Treatment for Communicable Diseases Market Share by Regions (2015-2020)
Table 15. Global Treatment for Communicable Diseases Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Treatment for Communicable Diseases Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Treatment for Communicable Diseases Market Growth Strategy
Table 21. Main Points Interviewed from Key Treatment for Communicable Diseases Players
Table 22. Global Treatment for Communicable Diseases Revenue by Players (2015-2020) (Million US$)
Table 23. Global Treatment for Communicable Diseases Market Share by Players (2015-2020)
Table 24. Global Top Treatment for Communicable Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Treatment for Communicable Diseases as of 2019)
Table 25. Global Treatment for Communicable Diseases by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Treatment for Communicable Diseases Product Solution and Service
Table 28. Date of Enter into Treatment for Communicable Diseases Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Treatment for Communicable Diseases Market Size by Type (2015-2020) (Million US$)
Table 31. Global Treatment for Communicable Diseases Market Size Share by Type (2015-2020)
Table 32. Global Treatment for Communicable Diseases Revenue Market Share by Type (2021-2026)
Table 33. Global Treatment for Communicable Diseases Market Size Share by Application (2015-2020)
Table 34. Global Treatment for Communicable Diseases Market Size by Application (2015-2020) (Million US$)
Table 35. Global Treatment for Communicable Diseases Market Size Share by Application (2021-2026)
Table 36. North America Key Players Treatment for Communicable Diseases Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Treatment for Communicable Diseases Market Share (2019-2020)
Table 38. North America Treatment for Communicable Diseases Market Size by Type (2015-2020) (Million US$)
Table 39. North America Treatment for Communicable Diseases Market Share by Type (2015-2020)
Table 40. North America Treatment for Communicable Diseases Market Size by Application (2015-2020) (Million US$)
Table 41. North America Treatment for Communicable Diseases Market Share by Application (2015-2020)
Table 42. Europe Key Players Treatment for Communicable Diseases Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Treatment for Communicable Diseases Market Share (2019-2020)
Table 44. Europe Treatment for Communicable Diseases Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Treatment for Communicable Diseases Market Share by Type (2015-2020)
Table 46. Europe Treatment for Communicable Diseases Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Treatment for Communicable Diseases Market Share by Application (2015-2020)
Table 48. China Key Players Treatment for Communicable Diseases Revenue (2019-2020) (Million US$)
Table 49. China Key Players Treatment for Communicable Diseases Market Share (2019-2020)
Table 50. China Treatment for Communicable Diseases Market Size by Type (2015-2020) (Million US$)
Table 51. China Treatment for Communicable Diseases Market Share by Type (2015-2020)
Table 52. China Treatment for Communicable Diseases Market Size by Application (2015-2020) (Million US$)
Table 53. China Treatment for Communicable Diseases Market Share by Application (2015-2020)
Table 54. Japan Key Players Treatment for Communicable Diseases Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Treatment for Communicable Diseases Market Share (2019-2020)
Table 56. Japan Treatment for Communicable Diseases Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Treatment for Communicable Diseases Market Share by Type (2015-2020)
Table 58. Japan Treatment for Communicable Diseases Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Treatment for Communicable Diseases Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Treatment for Communicable Diseases Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Treatment for Communicable Diseases Market Share (2019-2020)
Table 62. Southeast Asia Treatment for Communicable Diseases Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Treatment for Communicable Diseases Market Share by Type (2015-2020)
Table 64. Southeast Asia Treatment for Communicable Diseases Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Treatment for Communicable Diseases Market Share by Application (2015-2020)
Table 66. India Key Players Treatment for Communicable Diseases Revenue (2019-2020) (Million US$)
Table 67. India Key Players Treatment for Communicable Diseases Market Share (2019-2020)
Table 68. India Treatment for Communicable Diseases Market Size by Type (2015-2020) (Million US$)
Table 69. India Treatment for Communicable Diseases Market Share by Type (2015-2020)
Table 70. India Treatment for Communicable Diseases Market Size by Application (2015-2020) (Million US$)
Table 71. India Treatment for Communicable Diseases Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Treatment for Communicable Diseases Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Treatment for Communicable Diseases Market Share (2019-2020)
Table 74. Central & South America Treatment for Communicable Diseases Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Treatment for Communicable Diseases Market Share by Type (2015-2020)
Table 76. Central & South America Treatment for Communicable Diseases Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Treatment for Communicable Diseases Market Share by Application (2015-2020)
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Product
Table 81. Novartis Revenue in Treatment for Communicable Diseases Business (2015-2020) (Million US$)
Table 82. Novartis Recent Development
Table 83. Gilead Company Details
Table 84. Gilead Business Overview
Table 85. Gilead Product
Table 86. Gilead Revenue in Treatment for Communicable Diseases Business (2015-2020) (Million US$)
Table 87. Gilead Recent Development
Table 88. GSK Company Details
Table 89. GSK Business Overview
Table 90. GSK Product
Table 91. GSK Revenue in Treatment for Communicable Diseases Business (2015-2020) (Million US$)
Table 92. GSK Recent Development
Table 93. Janssen Pharmaceutical Company Details
Table 94. Janssen Pharmaceutical Business Overview
Table 95. Janssen Pharmaceutical Product
Table 96. Janssen Pharmaceutical Revenue in Treatment for Communicable Diseases Business (2015-2020) (Million US$)
Table 97. Janssen Pharmaceutical Recent Development
Table 98. Roche Company Details
Table 99. Roche Business Overview
Table 100. Roche Product
Table 101. Roche Revenue in Treatment for Communicable Diseases Business (2015-2020) (Million US$)
Table 102. Roche Recent Development
Table 103. BioCryst Pharmaceuticals Company Details
Table 104. BioCryst Pharmaceuticals Business Overview
Table 105. BioCryst Pharmaceuticals Product
Table 106. BioCryst Pharmaceuticals Revenue in Treatment for Communicable Diseases Business (2015-2020) (Million US$)
Table 107. BioCryst Pharmaceuticals Recent Development
Table 108. Merck Company Details
Table 109. Merck Business Overview
Table 110. Merck Product
Table 111. Merck Revenue in Treatment for Communicable Diseases Business (2015-2020) (Million US$)
Table 112. Merck Recent Development
Table 113. Boehringer Ingelheim Business Overview
Table 114. Boehringer Ingelheim Product
Table 115. Boehringer Ingelheim Company Details
Table 116. Boehringer Ingelheim Revenue in Treatment for Communicable Diseases Business (2015-2020) (Million US$)
Table 117. Boehringer Ingelheim Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Treatment for Communicable Diseases Market Share by Type: 2020 VS 2026
Figure 2. HIV Features
Figure 3. Influenza Features
Figure 4. TB Features
Figure 5. Malaria Features
Figure 6. Hepatitis Features
Figure 7. HPV Features
Figure 8. Global Treatment for Communicable Diseases Market Share by Application: 2020 VS 2026
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Other Case Studies
Figure 12. Treatment for Communicable Diseases Report Years Considered
Figure 13. Global Treatment for Communicable Diseases Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Treatment for Communicable Diseases Market Share by Regions: 2020 VS 2026
Figure 15. Global Treatment for Communicable Diseases Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Treatment for Communicable Diseases Market Share by Players in 2019
Figure 18. Global Top Treatment for Communicable Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Treatment for Communicable Diseases as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Treatment for Communicable Diseases Revenue in 2019
Figure 20. North America Treatment for Communicable Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Treatment for Communicable Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Treatment for Communicable Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Treatment for Communicable Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Treatment for Communicable Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Treatment for Communicable Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Treatment for Communicable Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Novartis Revenue Growth Rate in Treatment for Communicable Diseases Business (2015-2020)
Figure 29. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Gilead Revenue Growth Rate in Treatment for Communicable Diseases Business (2015-2020)
Figure 31. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. GSK Revenue Growth Rate in Treatment for Communicable Diseases Business (2015-2020)
Figure 33. Janssen Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Janssen Pharmaceutical Revenue Growth Rate in Treatment for Communicable Diseases Business (2015-2020)
Figure 35. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Roche Revenue Growth Rate in Treatment for Communicable Diseases Business (2015-2020)
Figure 37. BioCryst Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. BioCryst Pharmaceuticals Revenue Growth Rate in Treatment for Communicable Diseases Business (2015-2020)
Figure 39. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Merck Revenue Growth Rate in Treatment for Communicable Diseases Business (2015-2020)
Figure 41. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Boehringer Ingelheim Revenue Growth Rate in Treatment for Communicable Diseases Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed